• Home
  • Contact Us
  • Try it!
  • Blog
  • Vizit Graphs

Follow us

Recent Posts

  • Repositioning Safety May 22, 2020
  • Artificial Intelligence firm Biovista repositions four promising therapeutics against COVID-19 April 22, 2020
  • Business Development Agent in Japan February 12, 2020
  • High Throughput Layout and Copy Paste July 5, 2019
  • Biovista in World’s Top 20 AI Drug Development Companies March 22, 2019

Biovista Vizit

Biovista Vizit

  • Try it!
  • Blog
  • Vizit Graphs

1-METHYL-4-PHENYL-1-2-3-6-TETRAHYDROPYRIDINE

Drugs for Parkinson’s and Alzheimer’s

August 27, 2018Alzheimer's, Nervous System Disorders, Parkinson's, Vizit Graphs
Drugs for Parkinson’s and Alzheimer’s

Find drugs common to both Parkinson’s and Alzheimer’s diseases using Biovista Vizit. Explore the live graph.

Parkinson’s disease and Diabetes Type 2

August 27, 2018Diabetes, Metabolic Disorders, Nervous System Disorders, Parkinson's, Vizit Graphs
Parkinson disease and Diabetes Type 2

Incretin mimetics or GLP-1 receptor agonists are commonly used in Type 2 Diabetes. Recent evidence favors their use for the treatment of Parkinson’s disease. Explore the live graph.

Vizit Graphs Tag Cloud

IL10 HELICOBACTER PYLORI ACE2 IMMUNITY PSEUDOMONAS AERUGINOSA CELL DIFFERENTIATION RAS CHLOROQUINE NFKB1 AGING PD-1 APOE ACE INFLAMMATION TNF LACTATE DEHYDROGENASE IFNG IL1B CELL PROLIFERATION NEUTROPHILS PARKINSON DISEASE METFORMIN ALZHEIMER'S DISEASE INTERFERON COVID-19 SARS-COV-2 COGNITION CANDIDA ALBICANS CD4 LISTERIA MONOCYTOGENES ESCHERICHIA COLI TMPRSS2 INSULIN CANCER COAGULATION AUTOPHAGY ANGIOTENSIN II CASP3 IMMUNE RESPONSE APOPTOTIC PROCESS INFLAMMATORY RESPONSE RHEUMATOID ARTHRITIS STAPHYLOCOCCUS AUREUS IL6 CELL DEATH

© 2020 Biovista Vizit All Rights Reserved.